Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evolus Inc EOLS

Healthcare
Evolus, Inc. is a performance beauty company. Its primary market is the cash-pay aesthetic market, which consists of medical products. Its product candidates include Jeuveau and Evolysse. Jeuveau is its commercially available proprietary 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar... see more

Recent & Breaking News (NDAQ:EOLS)

Evolus to Report Fourth Quarter and Year End 2020 Results and Provide Business Update

GlobeNewswire March 23, 2021

Evolus Strengthens Balance Sheet Through a $25.5 Million Cash Infusion and Elimination of $127.4 Million of Debt and Milestone Payments

GlobeNewswire March 23, 2021

Evolus to Participate in Two Upcoming Investor Conferences

GlobeNewswire March 2, 2021

Evolus Announces Promotion of Crystal Muilenburg to Chief Marketing Officer

GlobeNewswire February 26, 2021

Evolus Announces Preliminary, Unaudited, Fourth Quarter and Full Year 2020 Net Revenue

GlobeNewswire February 23, 2021

Evolus to Participate in the 10th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire February 19, 2021

AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation

PR Newswire February 19, 2021

Evolus Provides Update on United States International Trade Commission (ITC) Case

GlobeNewswire December 16, 2020

EOLS Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020

ACCESSWIRE IA December 15, 2020

EOLS FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Reminds Evolus, Inc. Investors of Important December 15 Deadline in Securities Class Action - EOLS

GlobeNewswire December 15, 2020

Evolus Deadline Alert

Newsfile December 14, 2020

DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Evolus, Inc. (EOLS)

PR Newswire December 14, 2020

FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm

ACCESSWIRE IA December 14, 2020

EOLS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020

Business Wire December 14, 2020

DEADLINE ALERT for BMWYY, ZSAN, WFC, and EOLS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire December 14, 2020

DEADLINE TUESDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolus, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile December 14, 2020

EOLS Final Deadline Tomorrow: Rosen, A Global and Leading Law Firm, Reminds Evolus, Inc. Investors of Important December 15 Deadline in Securities Class Action - EOLS

Newsfile December 14, 2020

Evolus, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law

GlobeNewswire December 14, 2020

EOLS Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Evolus, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: December 15, 2020

ACCESSWIRE IA December 13, 2020

Evolus Shareholder Alert

Newsfile December 13, 2020